Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Møller-Larsen

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Journal of Clinical & Laboratory Immunology|July 1, 1986
Antibodies against herpes simplex virus in a group of healthy humans without reactions to herpes simplex virus antigens in blasttransformation assaysA Møller-Larsen
Scandinavian Journal of Immunology|January 1, 1979
Cell-mediated cytotoxicity during vaccinia virus revaccination in man: influence of antibodies and interferonA Møller-Larsen
Infection and Immunity|January 1, 1978
Humoral and cell-mediated immune responses in humans before and after revaccination with vaccinia virusA Møller-Larsen, S Haahr
Journal of Virological Methods|October 10, 1998
Isolation of a retrovirus from multiple sclerosis patients in self-generated Iodixanol gradientsA Møller-Larsen, T Christensen
Ugeskrift for Laeger|June 8, 1992
[Disseminated sclerosis and retrovirus]A Møller-Larsen, M Sommerlund, S Haahr
Clinical and Experimental Immunology|February 1, 1983
Immunological parameters in multiple sclerosis patients with special reference to the herpes virus groupS Haahr, A Møller-Larsen, E Pedersen
Neuroepidemiology|January 1, 1991
Multiple sclerosis as a retroviral disease? Epidemiological considerations in relation to HTLV-I epidemiologyS Haahr, M Sommerlund, A Møller-Larsen
Infection and Immunity|September 1, 1978
Lymphocyte-mediated cytotoxicity in humans during revaccination with vaccinia virusA Møller-Larsen, S Haahr, I Heron
Trends in Microbiology|September 1, 1994
A retroviral implication in multiple sclerosis?T Christensen, A Møller-Larsen, S Haahr
Infection and Immunity|November 1, 1978
Cellular and humoral immune responses to herpes simplex virus during and after primary gingivostomatitisA Møller-Larsen, S Haahr, F T Black
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Journal of Clinical & Laboratory Immunology|July 1, 1986
Antibodies against herpes simplex virus in a group of healthy humans without reactions to herpes simplex virus antigens in blasttransformation assaysA Møller-Larsen
Scandinavian Journal of Immunology|January 1, 1979
Cell-mediated cytotoxicity during vaccinia virus revaccination in man: influence of antibodies and interferonA Møller-Larsen
Infection and Immunity|January 1, 1978
Humoral and cell-mediated immune responses in humans before and after revaccination with vaccinia virusA Møller-Larsen, S Haahr
Journal of Virological Methods|October 10, 1998
Isolation of a retrovirus from multiple sclerosis patients in self-generated Iodixanol gradientsA Møller-Larsen, T Christensen
Ugeskrift for Laeger|June 8, 1992
[Disseminated sclerosis and retrovirus]A Møller-Larsen, M Sommerlund, S Haahr
Clinical and Experimental Immunology|February 1, 1983
Immunological parameters in multiple sclerosis patients with special reference to the herpes virus groupS Haahr, A Møller-Larsen, E Pedersen
Neuroepidemiology|January 1, 1991
Multiple sclerosis as a retroviral disease? Epidemiological considerations in relation to HTLV-I epidemiologyS Haahr, M Sommerlund, A Møller-Larsen
Infection and Immunity|September 1, 1978
Lymphocyte-mediated cytotoxicity in humans during revaccination with vaccinia virusA Møller-Larsen, S Haahr, I Heron
Trends in Microbiology|September 1, 1994
A retroviral implication in multiple sclerosis?T Christensen, A Møller-Larsen, S Haahr
Infection and Immunity|November 1, 1978
Cellular and humoral immune responses to herpes simplex virus during and after primary gingivostomatitisA Møller-Larsen, S Haahr, F T Black
Pageof 4